Spotlight Series: Mixed Dyslipidemia
Back to series
This case-based series seeks to educate healthcare providers on lipid-lowering management
strategies by reviewing techniques surrounding LDL-C lowering and the role of additional
lipoprotein analysis in risk stratification and treatment, treatment of mixed dyslipidemia
in metabolic syndrome and diabetes mellitus, and therapies to raise HDL-C.
Mixed Dyslipidemia Topics
Spotlight Series Planning Committee
Spotlight Series Chair:
Tyler J. Gluckman, MD
Faculty:
Kim K. Birtcher, MS, PharmD
Roger S. Blumenthal, MD, FACC, FAHA
Laurie A. Kopin, MS, ANP
Neil J. Stone, MD, FAHA
Daniel J. Rader, MD, FAHA
Spotlight Series Speakers
We will fulfill your request with an AHA APPROVED and TRAINED SPEAKER
located in your area. Once your speaking engagement is confirmed, you will receive
the speaker's name and background information.
Supported by an educational grant from Solvay Pharmaceuticals and Abbott Pharmaceuticals